Welcome to PsychU!

World Bipolar Day – Bipolar Together

World Bipolar Day – Bipolar Together

World Bipolar Day, celebrated annually on March 30th, plays a crucial role in raising global awareness about bipolar disorder and the challenges faced by those living with the condition. This day aims to eliminate social stigma, promote understanding, and encourage individuals to seek help and support. By sharing personal stories and spreading knowledge, World Bipolar Day fosters a sense of community and solidarity, reminding those affected that they are not alone. It also highlights the importance of contributing to improved mental health outcomes and quality of life for individuals with bipolar disorder. Join us as both providers and patients share their thoughts and perspectives of on the significance of World Bipolar Day and the impact of living with bipolar disorder.

Featuring

Mauricio-Tohen

Mauricio Tohen, MD, DrPH, MBA

Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico

More
Mauricio Tohen, MD, DrPH, MBA, is a University Distinguished Professor and Chairman of the Department of Psychiatry at the University of New Mexico Health Science Center, Albuquerque NM. From 2009 to 2013 he was a Professor of Psychiatry and The Krus Endowed Chair in Psychiatry at the University of Texas Health Science Center at San Antonio. Dr. Tohen received his medical degree from the National University of Mexico and his Doctor of Public Health degree in Epidemiology from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, a clinical fellowship at McLean Hospital and Harvard Medical School, and a teaching fellowship in Epidemiology at the Harvard School of Public Health. From 1988 to 1997, Dr. Tohen was the Clinical Director of the Bipolar and Psychotic Disorders Program at McLean Hospital. From 1997 to 2008 he was a member of Lilly Research Laboratories reaching the senior-most scientific level of Distinguished Lilly Scholar. In 2009 he joined the University of Texas Health Science Center at San Antonio as the Head of the Division of Mood and Anxiety Disorders. Dr. Tohen received a National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University. He also received a FIRST award from the NIMH, the Pope Award from McLean Hospital, and a NARSAD Young Investigator Award and the Simon Bolivar Award from the American Psychiatric Association. In 2014 he was named by Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. Honorees were the scientists who ranked in the Top 1 percent by citations of their published work in 21 broad fields between 2002 and 2012.
Anyi-Atabong

Anyi Atabong, DNP, PMHNP-BC, FNP-C

Adjunct Faculty Member – Helene Fuld School of Nursing, Coppin State University, CEO – Capital Multi Health Group (Maryland)

More
Anyi Atabong, DNP, PMHNP-BC, FNP-C, is a Psychiatric and Family Nurse Practitioner and currently holds licenses in Maryland, Virginia and Washington, DC.  She has over 15 years of hands-on patient care experience working in multiple healthcare settings, including emergency rooms, home health, HIV clinics, substance abuse programs and outpatient community clinics.  Dr. Atabong is CEO and co-founder of Capital Multi Health Group in Maryland as well as an adjunct faculty member at Coppin State University’s Helene Fuld School of Nursing.  She is an active member of several professional organizations, including the American Academy of Nurse Practitioners and the American Psychiatric Nurses Association.  Dr. Atabong earned her Bachelor of Science in Nursing and her Master of Science in Nursing as a Family Nurse Practitioner from Coppin State University, received her Psychiatric Mental Health Nurse Practitioner certification from the University of Cincinnati and completed a Doctorate of Nursing Practice from Duke University.

Doctors Mauricio Tohen, MD and Anyi Atabong, DNP are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. 

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

February 2025    US.CORP.X.25.00032